XSS in Philips Clinical Collaboration Platform
CVE-2020-14525
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 3.5 (Low). Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N.
EPSS exploit prediction
EPSS: 0.005 (39.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 40th percentile — 39.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000
Affected products
Weakness classification (CWE)
References
- us-cert.cisa.gov/ics/advisories/icsma-20-261-01 (US Government Resource, Third Party Advisory)
- www.philips.com/a-w/security/security-advisories/product-security-2020.html
Frequently asked questions
- What is CVE-2020-14525?
- CVE-2020-14525 is a low-severity vulnerability in Philips Clinical Collaboration Platform, classified under Improper Neutralization of Script in Attributes in a Web Page. CVSS score: 3.5/10. Published 2020-09-18.
- How severe is CVE-2020-14525?
- Low severity. CVSS v3 base score is 3.5 out of 10.